Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: Formulation and clinical implications

Indian Journal of Experimental Biology

Volumn 43, Issue 3, 2005, Pages 233-240

  Kalariya, Mayur ^a   Padhi, Bijay Kumar ^a   Chougule, Mahavir ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Chronic eczema; Clobetasol propionate; High pressure homogenization technique; Mean flux; Solid lipid nanoparticles

Indexed keywords

CLOBETASOL; DRUG; DRUG CARRIER; DRUG DERIVATIVE; LIPID;

ARTICLE; CADAVER; CHEMISTRY; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECZEMA; HUMAN; INFLAMMATION; NANOTECHNOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SKIN; SOLUBILITY; TEMPERATURE; TIME;

CADAVER; CLOBETASOL; DOUBLE-BLIND METHOD; DRUG CARRIERS; ECZEMA; HUMANS; INFLAMMATION; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; NANOTECHNOLOGY; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SKIN; SOLUBILITY; TEMPERATURE; TIME FACTORS;

EID: 14944341766     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Halder B, Basic principles of diagnosis and treatment of eczema, Indian J Dermatol, 30 (1985) 19.
2. th edition (Popular Prakashan, Mumbai) 1997, 809.
3. th edition, edited by Perry B Molinoff and Raynod W Rudan, (McGraw Hill, New York) 2001, 1667 & 1804.
4. Bondi E E & Kligman A M, Adverse effects of topical corti-costeroids, Prog Dermatol 14 (1980) 1.
5. Wester R C & Maibach H I, Percutaneous absorption of topical corticosteroids, Curr Probl Dermatol, 21(1993) 45.
6. Patel V B, Misra A N & Marfatia Y S, Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications, Pharm Dev Tech, 5 (2000) 455.
7. Patel V B, Misra A N & Marfatia Y S, Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne, Drug Dev Ind Pharm, 27:8 (1999) 863.
8. Patel V B, Misra A N & Marfatia Y S, Clinical assessment of the combination therapy with liposomal gels of tretinoin and benzoyl peroxide in acne, AAPS Pharm Sci Tech 2:3 (2001) 1.
9. Patel V B, Misra A N & Marfatia Y S, Topical dosage form of liposomal clofazimine: research and clinical implications, Pharmazie, 54 (1999) 448.
10. Kalariya M, Padhi B K, Chougule M & Misra Ambikanandan, Methotrexate loaded solid lipid nanoparticles for topical treatment of psoriasis: Formulation and clinical implications, Drug Del Tech, Oct (2004) (in press).
11. Jenning V, Feste Lipid Nanopartikel ais tragersystem for die dermale application von retinal, Ph.D. Thesis, Free University of Berlin, 1999.
12. Santos Maia C, Mehnert W & Schafer-Korting M, Solid lipid nanoparticles as drug carriers for topical glucocorticoids, Int J Pharm, 196 (2000) 165.
13. Muller R H & Dingler A, Feste Lipid-nanopartikel (Lipopearls™) alsneuartiger carrier fur kosmetische und dermatologische Wirkstoff, Pharmazeut Zeitung Dermopharma, (1998)11.
14. Muller R H & Dingler A, The next generation after the liposomes: Solid lipid nanoparticles (SLN™, Lipopearls™) as dermal carrier in cosmetics, Euro Cosmetics, 7/8 (1998)19.
15. Jeffes E W III, McCullough J L, Pittelkow M R, McCormick A, Almanzor J Liu, Dang G, Voss M, Voss K, Scholtzhauer J & Weinstein G D, Methotrexate therapy for psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of Methotrexate, J Invest Dermatol, 104 (1995) 183.
16. Ball M A, McCullough J L & Weinstein G D, Percutaneous absorption of Methotrexate: effect on epidermal DNA synthesis in hairless mice, J Invest Dermatol, 79 (1982) 7.
17. Hu F Q, Yuan H, Zhang H H & Fang M, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in a aqueous system and physicochemical characterization, Int J Pharm, 239 (2002) 121.
18. th July 1994.
19. Muller R H, Schwarz C, Mehnert W & Lucks J S, Production of solid lipid nanoparticles (SLN) for controlled drug delivery, Control Release Bioact Mater (Proc Int Symp) 20 (1993) 480.
20. Taguchi G, Taguchi method: Design of experiment, quality engineering series Vol 4, edited by Konishi S (American Supplier Institute Inc, Dearborn) 1993.
21. rd edition (CBS publishers, New Delhi) 1997, 542.
22. Franz T J, Percutaneous absorption on the relevance of in vitro data, J Invest Dermatol, 67 (1975) 190.
23. Washington C, Drug release from micro disperse system: a critical review. Int J Pharm, 58 (1990) 1.
24. Muller R H, Mader K & Gohla S, Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art, Eur J Pharm Biopharm, 50 (2000) 161.
25. Siekmann B & Westensen K, Sub-micron sized parenteral carrier systems based on solid lipid, Pharm Pharmacol Lett, 1 (1992) 123.
26. Ahlin P & Kristl J, Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions, Acta Pharm, 48 (1998) 257.
27. Mehnert W & Mader K, Solid lipid nanoparticles production, characterization and applications, Adv Drug Del Rev, 47 (2001) 165.
28. ZurMuhlen A, Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilitat, Charakterisierung, Freisetzungsverhalten und mechanismen, Ph.D. Thesis, Free University of Berlin, 1996.
29. Jenning V, Gysler A, Schafer-Korting M & Gohla S, Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug penetration into porcine skin, Eur J Pharm Biopharm, 49 (2000) 211.
30. Jenning V, Schafer-Korting M & Gohla S, Vitamin A loaded solid lipid nanoparticles for topical application: drug release properties, J Control Rel, 66:2-3 (2000) 115.
31. Dingler A, Feste Lipid-Nanopartikel als kolloidale Wirkstofftragersysteme zur dermalen Applikation, Ph.D. Thesis, Free University of Berlin, 1998.
32. Jenning V & Gohla S, Characterisation of solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids, Int J Pharm, 205 (2000) 15.
33. Dingler A, Hildebrand G, Niehus H & Muller R H, Cosmetic anti-aging formulation based on vitamin E-loaded solid lipid nanoparticles, Control Release Bioact Mater (Proc Int Symp) 25 (1998) 433.
34. nd World Meeting APGI/APV, (1998) 619.
35. Higuchi T, Rate of release of medicaments from ointment bases containing drugs in suspension, J Pharm Sci, 50 (1961) 874.
36. Wade A & Walker P J, Hand book of pharmaceutical excipients (Pharmaceutical Press, London) 1986, 63.